Human T cells are genetically edited using CRISPR/Cas9 technology to remove both CD7 and the T-cell receptor (TCR) α chain (TRAC) to generate universal CAR-T cells (CD7 UCAR-T cells), which target cancer cells expressing CD7 without attacking the healthy T cells. This evidence concerns the gene CD7 and cancer.